Postpartum Depression Management Market: Global Industry Analysis 2017-2021 and Opportunity Assessment 2022-2032
A recent market study published by FMI on Postpartum Depression Management offers a global industry analysis for 2017-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
By Treatment Type:
- Anti-Depressant Drugs
- Bupropion
- Fluoxetine
- Doxepin
- Others
- Hospital
- Retail
- Drug Stores
- E-Commerce
- North America
- Latin America
- Middle East and Africa
- Europe
- Asia Pacific
Executive Summary
The executive summary of the Postpartum Depression Management Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Postpartum Depression Management.
Chapter 01 - Market Overview
Readers can find the detailed segmentation and definition of the Postpartum Depression Management Market in this chapter, which will help to understand basic information about Postpartum Depression Management. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Postpartum Depression Management Market report.
Chapter 02 - Market Background
This chapter includes detailed analysis of the By Nature processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 - Global Postpartum Depression Management Market Demand Analysis 2017-2021 and Forecast, 2022-2032
The chapter include historical market value (US$ XX Billion) analysis (2017-2021) and current and future market value (US$ 173.9 Million) and volume (3.8 %) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 - Global Postpartum Depression Management Market - Pricing Analysis
Based on By Nature, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 - Global Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032, By Treatment Type
Based on By Treatment Type, Postpartum Depression Management Market is segmented into Anti-Depressant Drugs, Bupropion, Fluoxetine, Doxepin, Others. This section also offers market attractiveness analysis based on By Treatment Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Treatment Type.
Chapter 06 - Global Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel
Based on By Distribution Channel, Postpartum Depression Management Market is segmented into Hospital, Retail, Drug Stores, E-Commerce. This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.
Chapter 07 - Global Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032, By Region
Based on By Region, Postpartum Depression Management Market is segmented into North America,Latin America,Europe,East Asia,South Asia & Pacific,Middle East & Africa. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.
Chapter 08 - North America Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Postpartum Depression Management in the North American Region, along with a country-wise assessment that includes the US and Canada. Readers can also find Regional trends, regulations, and market growth based on different segment and countries in the North America Region.
Chapter 09 - Latin America Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Postpartum Depression Management in the Latin America Region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Postpartum Depression Management Market in the Latin America Region.
Chapter 10 - Europe Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Postpartum Depression Management in the European Region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Postpartum Depression Management Market in the Regional market.
Chapter 11 - East Asia Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Postpartum Depression Management in the East Asia Region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Postpartum Depression Management Market in the Regional market.
Chapter 12 - South Asia Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Postpartum Depression Management in the South Asia Region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Postpartum Depression Management Market in the Regional market.
Chapter 13 - Middle East and Africa Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Postpartum Depression Management in the MEA Region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and Regional trends, which are impacting growth of the Postpartum Depression Management Market in the Regional market.
Chapter 14 - Key Countries Postpartum Depression Management Market Analysis 2017-2021 and Forecast 2022-2032
This chapter offers insights into how the Postpartum Depression Management Market is expected to grow in major countries globally.
Chapter 15 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 16 - Competition Deep Dive (Tentative List)
This chapter includes company overview, By Nature portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Sage Therapeutics Inc., Cipla Limited, Sun Pharmaceutical Industries Ltd., Anikem Laboratories, Intas Pharmaceuticals Ltd., Mylan N.V., Sumika Fine Chemicals Co Ltd.
Chapter 17 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Postpartum Depression Management report.
Chapter 18 - Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Postpartum Depression Management Market.
- 1. Executive Summary | Postpartum Depression Management Market
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
- 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Treatment
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2017 to 2021
- 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2022 to 2032
- 5.3.1. Anti-Depressant Drugs
- 5.3.2. New Anti-Depressant Drugs
- 5.3.3. SAGE-547
- 5.3.4. Bupropion
- 5.3.5. Escitalopram
- 5.3.6. Fluoxetine
- 5.3.7. Paroxetine
- 5.3.8. Sertraline
- 5.3.9. Old Anti-Depressant Drugs
- 5.3.10. Amitriptyline
- 5.3.11. Desipramine
- 5.3.12. Others
- 5.4. Y-o-Y Growth Trend Analysis By Treatment, 2017 to 2021
- 5.5. Absolute $ Opportunity Analysis By Treatment, 2022 to 2032
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2021
- 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032
- 6.3.1. Hospital Pharmacies
- 6.3.2. Retail Pharmacies
- 6.3.3. Drug Stores
- 6.3.4. E-commerce
- 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021
- 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
- 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. Asia Pacific
- 7.3.5. Middle East and Africa
- 7.4. Market Attractiveness Analysis By Region
- 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 8.2.1. By Country
- 8.2.1.1. United States of America
- 8.2.1.2. Canada
- 8.2.2. By Treatment
- 8.2.3. By Distribution Channel
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Treatment
- 8.3.3. By Distribution Channel
- 8.4. Key Takeaways
- 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Rest of Latin America
- 9.2.2. By Treatment
- 9.2.3. By Distribution Channel
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Treatment
- 9.3.3. By Distribution Channel
- 9.4. Key Takeaways
- 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. United Kingdom
- 10.2.1.3. France
- 10.2.1.4. Spain
- 10.2.1.5. Italy
- 10.2.1.6. Rest of Europe
- 10.2.2. By Treatment
- 10.2.3. By Distribution Channel
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Treatment
- 10.3.3. By Distribution Channel
- 10.4. Key Takeaways
- 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 11.2.1. By Country
- 11.2.1.1. China
- 11.2.1.2. Japan
- 11.2.1.3. South Korea
- 11.2.1.4. India
- 11.2.1.5. Malaysia
- 11.2.1.6. Singapore
- 11.2.1.7. Australia
- 11.2.1.8. New Zealand
- 11.2.1.9. Rest of Asia-Pacific
- 11.2.2. By Treatment
- 11.2.3. By Distribution Channel
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Treatment
- 11.3.3. By Distribution Channel
- 11.4. Key Takeaways
- 12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 12.2.1. By Country
- 12.2.1.1. GCC Countries
- 12.2.1.2. South Africa
- 12.2.1.3. Israel
- 12.2.1.4. Rest of Middle East and Africa
- 12.2.2. By Treatment
- 12.2.3. By Distribution Channel
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Treatment
- 12.3.3. By Distribution Channel
- 12.4. Key Takeaways
- 13. Key Countries Market Analysis
- 13.1. United States of America
- 13.1.1. Pricing Analysis
- 13.1.2. Market Share Analysis, 2021
- 13.1.2.1. By Treatment
- 13.1.2.2. By Distribution Channel
- 13.2. Canada
- 13.2.1. Pricing Analysis
- 13.2.2. Market Share Analysis, 2021
- 13.2.2.1. By Treatment
- 13.2.2.2. By Distribution Channel
- 13.3. Brazil
- 13.3.1. Pricing Analysis
- 13.3.2. Market Share Analysis, 2021
- 13.3.2.1. By Treatment
- 13.3.2.2. By Distribution Channel
- 13.4. Mexico
- 13.4.1. Pricing Analysis
- 13.4.2. Market Share Analysis, 2021
- 13.4.2.1. By Treatment
- 13.4.2.2. By Distribution Channel
- 13.5. Germany
- 13.5.1. Pricing Analysis
- 13.5.2. Market Share Analysis, 2021
- 13.5.2.1. By Treatment
- 13.5.2.2. By Distribution Channel
- 13.6. United Kingdom
- 13.6.1. Pricing Analysis
- 13.6.2. Market Share Analysis, 2021
- 13.6.2.1. By Treatment
- 13.6.2.2. By Distribution Channel
- 13.7. France
- 13.7.1. Pricing Analysis
- 13.7.2. Market Share Analysis, 2021
- 13.7.2.1. By Treatment
- 13.7.2.2. By Distribution Channel
- 13.8. Spain
- 13.8.1. Pricing Analysis
- 13.8.2. Market Share Analysis, 2021
- 13.8.2.1. By Treatment
- 13.8.2.2. By Distribution Channel
- 13.9. Italy
- 13.9.1. Pricing Analysis
- 13.9.2. Market Share Analysis, 2021
- 13.9.2.1. By Treatment
- 13.9.2.2. By Distribution Channel
- 13.10. China
- 13.10.1. Pricing Analysis
- 13.10.2. Market Share Analysis, 2021
- 13.10.2.1. By Treatment
- 13.10.2.2. By Distribution Channel
- 13.11. Japan
- 13.11.1. Pricing Analysis
- 13.11.2. Market Share Analysis, 2021
- 13.11.2.1. By Treatment
- 13.11.2.2. By Distribution Channel
- 13.12. South Korea
- 13.12.1. Pricing Analysis
- 13.12.2. Market Share Analysis, 2021
- 13.12.2.1. By Treatment
- 13.12.2.2. By Distribution Channel
- 13.13. Malaysia
- 13.13.1. Pricing Analysis
- 13.13.2. Market Share Analysis, 2021
- 13.13.2.1. By Treatment
- 13.13.2.2. By Distribution Channel
- 13.14. Singapore
- 13.14.1. Pricing Analysis
- 13.14.2. Market Share Analysis, 2021
- 13.14.2.1. By Treatment
- 13.14.2.2. By Distribution Channel
- 13.15. Australia
- 13.15.1. Pricing Analysis
- 13.15.2. Market Share Analysis, 2021
- 13.15.2.1. By Treatment
- 13.15.2.2. By Distribution Channel
- 13.16. New Zealand
- 13.16.1. Pricing Analysis
- 13.16.2. Market Share Analysis, 2021
- 13.16.2.1. By Treatment
- 13.16.2.2. By Distribution Channel
- 13.17. GCC Countries
- 13.17.1. Pricing Analysis
- 13.17.2. Market Share Analysis, 2021
- 13.17.2.1. By Treatment
- 13.17.2.2. By Distribution Channel
- 13.18. South Africa
- 13.18.1. Pricing Analysis
- 13.18.2. Market Share Analysis, 2021
- 13.18.2.1. By Treatment
- 13.18.2.2. By Distribution Channel
- 13.19. Israel
- 13.19.1. Pricing Analysis
- 13.19.2. Market Share Analysis, 2021
- 13.19.2.1. By Treatment
- 13.19.2.2. By Distribution Channel
- 14. Market Structure Analysis
- 14.1. Competition Dashboard
- 14.2. Competition Benchmarking
- 14.3. Market Share Analysis of Top Players
- 14.3.1. By Regional
- 14.3.2. By Treatment
- 14.3.3. By Distribution Channel
- 15. Competition Analysis
- 15.1. Competition Deep Dive
- 15.1.1. SAGE Therapeutics Inc.
- 15.1.1.1. Overview
- 15.1.1.2. Product Portfolio
- 15.1.1.3. Profitability by Market Segments
- 15.1.1.4. Sales Footprint
- 15.1.1.5. Strategy Overview
- 15.1.1.5.1. Marketing Strategy
- 15.1.2. Cipla Limited
- 15.1.2.1. Overview
- 15.1.2.2. Product Portfolio
- 15.1.2.3. Profitability by Market Segments
- 15.1.2.4. Sales Footprint
- 15.1.2.5. Strategy Overview
- 15.1.2.5.1. Marketing Strategy
- 15.1.3. Sun Pharmaceutical Industries Ltd.
- 15.1.3.1. Overview
- 15.1.3.2. Product Portfolio
- 15.1.3.3. Profitability by Market Segments
- 15.1.3.4. Sales Footprint
- 15.1.3.5. Strategy Overview
- 15.1.3.5.1. Marketing Strategy
- 15.1.4. Anikem Laboratories
- 15.1.4.1. Overview
- 15.1.4.2. Product Portfolio
- 15.1.4.3. Profitability by Market Segments
- 15.1.4.4. Sales Footprint
- 15.1.4.5. Strategy Overview
- 15.1.4.5.1. Marketing Strategy
- 15.1.5. Intas Pharmaceuticals Ltd.
- 15.1.5.1. Overview
- 15.1.5.2. Product Portfolio
- 15.1.5.3. Profitability by Market Segments
- 15.1.5.4. Sales Footprint
- 15.1.5.5. Strategy Overview
- 15.1.5.5.1. Marketing Strategy
- 15.1.6. Mylan N.V.
- 15.1.6.1. Overview
- 15.1.6.2. Product Portfolio
- 15.1.6.3. Profitability by Market Segments
- 15.1.6.4. Sales Footprint
- 15.1.6.5. Strategy Overview
- 15.1.6.5.1. Marketing Strategy
- 15.1.7. Sumika Fine Chemicals Co Ltd.
- 15.1.7.1. Overview
- 15.1.7.2. Product Portfolio
- 15.1.7.3. Profitability by Market Segments
- 15.1.7.4. Sales Footprint
- 15.1.7.5. Strategy Overview
- 15.1.7.5.1. Marketing Strategy
- 15.1.8. Aurobindo Pharma
- 15.1.8.1. Overview
- 15.1.8.2. Product Portfolio
- 15.1.8.3. Profitability by Market Segments
- 15.1.8.4. Sales Footprint
- 15.1.8.5. Strategy Overview
- 15.1.8.5.1. Marketing Strategy
- 15.1.9. Lupin
- 15.1.9.1. Overview
- 15.1.9.2. Product Portfolio
- 15.1.9.3. Profitability by Market Segments
- 15.1.9.4. Sales Footprint
- 15.1.9.5. Strategy Overview
- 15.1.9.5.1. Marketing Strategy
- 15.1.10. Accord Healthcare
- 15.1.10.1. Overview
- 15.1.10.2. Product Portfolio
- 15.1.10.3. Profitability by Market Segments
- 15.1.10.4. Sales Footprint
- 15.1.10.5. Strategy Overview
- 15.1.10.5.1. Marketing Strategy
- 16. Assumptions & Acronyms Used
- 17. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook